Header

UZH-Logo

Maintenance Infos

ESF-EMBO Symposium "Molecular biology and innovative therapies in sarcomas of childhood and adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland


Schäfer, Beat W; Koscielniak, Ewa; Kovar, Heinrich; Fulda, Simone (2013). ESF-EMBO Symposium "Molecular biology and innovative therapies in sarcomas of childhood and adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland. Frontiers in Oncology:3:142.

Abstract

Rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) are among the most common pediatric sarcomas (Arndt et al., 2012). Despite sarcomas representing a highly heterogeneous group of tumors, ES and alveolar RMS (ARMS) typically share one common genetic characteristic, namely a specific chromosomal translocation (Helman and Meltzer, 2003; Lessnick and Ladanyi, 2012). These translocations generate fusion proteins, which are composed of two transcription factors (TF). Typically, one TF is a developmentally regulated factor that is essential for proper specification of a given lineage and provides the DNA-binding domain, while the partner TF contributes a transactivation domain that drives aberrant expression of target genes. Based on these common genetic characteristics, the first ESF-EMBO research conference entitled "Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence" with special focus on RMS and ES was held at the Polonia Castle in Pultusk, Poland. The conference gathered 70 participants from more than 15 countries and several continents representing most research groups that are active in this field.

Abstract

Rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) are among the most common pediatric sarcomas (Arndt et al., 2012). Despite sarcomas representing a highly heterogeneous group of tumors, ES and alveolar RMS (ARMS) typically share one common genetic characteristic, namely a specific chromosomal translocation (Helman and Meltzer, 2003; Lessnick and Ladanyi, 2012). These translocations generate fusion proteins, which are composed of two transcription factors (TF). Typically, one TF is a developmentally regulated factor that is essential for proper specification of a given lineage and provides the DNA-binding domain, while the partner TF contributes a transactivation domain that drives aberrant expression of target genes. Based on these common genetic characteristics, the first ESF-EMBO research conference entitled "Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence" with special focus on RMS and ES was held at the Polonia Castle in Pultusk, Poland. The conference gathered 70 participants from more than 15 countries and several continents representing most research groups that are active in this field.

Statistics

Citations

Altmetrics

Downloads

81 downloads since deposited on 08 Nov 2013
5 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2013
Deposited On:08 Nov 2013 08:23
Last Modified:07 Dec 2017 23:28
Publisher:Frontiers Research Foundation
ISSN:2234-943X
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.3389/fonc.2013.00142
PubMed ID:23761860

Download

Download PDF  'ESF-EMBO Symposium "Molecular biology and innovative therapies in sarcomas of childhood and adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland'.
Preview
Content: Published Version
Language: English
Filetype: PDF
Size: 404kB
View at publisher
Licence: Creative Commons: Attribution 3.0 Unported (CC BY 3.0)